Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Enrollment ceased in phase III NSCLC study of Sarasar

Feb. 10, 2004

Novel steroid sulphate inhibitor for breast tumor therapy reported

Feb. 10, 2004

AP-5346 makes preclinical and clinical progress

Feb. 9, 2004

Alimta approved for use with cisplatin for malignant pleural mesothelioma

Feb. 9, 2004

Orphan drug status for BCX-1777 for T-cell non-Hodgkin's lymphoma

Feb. 9, 2004

DepoCyte launched in Europe

Feb. 9, 2004

French team reports novel proapoptitic and antiangiogenic agents for cancer therapy

Feb. 9, 2004

Abbott and Caprion collaborate on drug discovery for lung cancer

Feb. 9, 2004

Phase I ThermoDox protocol amendments allowed

Feb. 6, 2004

IP3R3 involved in peritoneal metastasis of gastric cancers

Feb. 6, 2004

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...